CD274 and cancer: However, recent research has developed a biomimetic ICI protein (EMS-PDBP) that specifically targets intracellular PD-L1 and leverages erythrocyte membrane encapsulation to enhance selective uptake in cancer cells, thereby minimizing its effects on lung fibroblasts.